MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, APLT had -$18,476K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$18,476K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-18,990 -43,155
Stock-based compensation expense
1,142 3,587
Amortization of insurance premium
0 0
Amortization of operating lease right-of-use assets
111 213
Amortization of leasehold improvements
0 1
Change in operating lease liability
-102 -193
Change in fair value of warrant liabilities
2,369 -4,541
Prepaid expenses
15,619 -158
Accounts payable
-135 428
Accrued expenses and other current liabilities
12,823 -5,475
Other liabilities
0 0
Net cash used in operating activities
-18,401 -48,977
Net cash provided by investing activities
0 0
Proceeds from issuance of common stock, net of issuance costs
-1 -
Employee stock purchase plan common stock issuance
20 -
Restricted stock units released settlement of payroll taxes
94 -
Repayments of short-term borrowings
0 0
Exercise of common warrants
0 0
Exercise of stock options
0 0
Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs
-0
Net cash (used) provided by financing activities
-75 0
Net (decrease) increase in cash and cash equivalents
-18,476 -48,977
Cash and cash equivalents at beginning of period
79,398 -
Cash and cash equivalents at end of period
11,945 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Applied Therapeutics, Inc. (APLT)

Applied Therapeutics, Inc. (APLT)